
Representatives of the World Vapers Alliance (WVA) have submitted an "e-cigarette products directive" to members of the European Parliament in Strasbourg to demonstrate how e-cigarettes can be regulated to maximize their potential as a harm reduction tool for tobacco.
The event was launched during the scrutiny of the Tobacco Products Directive by European legislators. In response to the European Commission's public call for evidence, WVA publicly opposed flavor bans and excessive regulations.
The support of electronic cigarettes allows us to overcome smoking and save the lives of 19 million people through reasonable regulation," said Michael Landl, director of WVA. "The EU's evidence-gathering campaign received a record-breaking 24,000 responses, demonstrating that consumers seek reduced tobacco harm, and electronic cigarettes have proven to be one of the most successful ways thus far.
The EU needs to end the current discussion around the ban of flavors, and electronic cigarettes must remain affordable and user-friendly. Now is the time for the EU to fully support reducing tobacco harm and placing electronic cigarettes at its core.
The event was launched in Strasbourg, France, and will be spread across 10 cities in six countries from October to November 2022.
We will host community events in France, Poland, the Czech Republic, Italy, Portugal, and Belgium to raise awareness about one of the most critical legislative issues regarding the future of e-cigarettes. It is now time for politicians to listen to consumers and science," stated Randall in a press release.
WVA has launched a petition against harmful e-cigarette regulations, such as flavor bans or taxation of e-cigarette products. The signatures will be delivered to Members of the European Parliament at the end of the November tour.
Statement:
This article is compiled from third-party information and is intended solely for industry exchange and learning.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of its content. The translation of this article is only intended for industry-related communication and research.
Due to limitations in translation capability, the translated article may not fully express the original content. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign statements and positions.
The copyright of the compiled information belongs to the original media and the author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









